Klaus M Strebhardt - Gynecology

Author Information

Klaus M. Strebhardt is affiliated with the Department of Gynecology at Goethe-University, Frankfurt am Main, and the German Cancer Consortium (DKTK) / German Cancer Research Center, partner site, Frankfurt a. M. His research primarily focuses on gynecological cancers, particularly cervical and ovarian cancer.

Research Contributions

Klaus M. Strebhardt has made significant contributions to the field of gynecological oncology through his research on molecular markers, cell cycle regulation, and kinase inhibitors. His work spans various aspects of cancer biology, including DNA damage response, the roles of polo-like kinases, and the development of selective inhibitors. In recent years, his studies have provided novel insights into the mechanisms of cancer progression and potential therapeutic targets, particularly in cervical and ovarian cancers.

Aliases

Klaus M. Strebhardt is also known by other names including K Strebhardt, K. Strebhardt, and Klaus Strebhardt.

Publication and Citation Metrics

Metric	Value
Total Citation Count	6789
h-index	46
Total Number of Papers	133

Publications:

The Role of DAPK1 in the Cell Cycle Regulation of Cervical Cancer Cells and in Response to Topotecan

DOI: 10.7150/jca.66492

Year: 2022

Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer

DOI: 10.3390/cells10051176

Year: 2021

Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer

DOI: 10.3390/cancers13225748

Year: 2021

A Spatial and Functional Interaction of a Heterotetramer Survivin–DNA-PKcs Complex in DNA Damage Response

DOI: 10.1158/0008-5472.CAN-20-2931

Year: 2021

Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors.

DOI: 10.1021/acs.jmedchem.0c02144

Year: 2021

Structure-based design of selective salt-inducible kinase (SIK) inhibitors

DOI: 10.1101/2021.04.08.439011

Year: 2021

Inhibition of PLK1-dependent EBNA2 phosphorylation promotes lymphomagenesis in EBV-infected mice

DOI: 10.1101/2021.03.29.437455

Year: 2021

PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice

DOI: 10.15252/embr.202153007

Year: 2021

The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells

DOI: 10.3390/cancers13153658

Year: 2021

Targeting CDK9 for Anti-Cancer Therapeutics

DOI: 10.3390/cancers13092181

Year: 2021

What Impact Does Patient Interaction Have?

How to Balance Work and Life?

What is the Parietal Peritoneum?

What are the Different Types of Metoidioplasty?

What Role Does Postoperative Follow-Up Play in Managing Complications?

What are Anti-Inflammatory Agents?

What Qualifications Do Mental Health Counselors Need?

Why is Biocompatibility Important in Gynecology?

Why are Professional Organizations Important?

What is Cytochrome P450?

Partnered Content Networks

Relevant Topics